Roberta Resaz
YOU?
Author Swipe
View article: MRI-activated magnetoelectric nanoparticles as theranostic agents
MRI-activated magnetoelectric nanoparticles as theranostic agents Open
View article: Silk fibroin nanoparticles for locoregional cancer therapy: Preliminary biodistribution in a murine model and microfluidic GMP-like production
Silk fibroin nanoparticles for locoregional cancer therapy: Preliminary biodistribution in a murine model and microfluidic GMP-like production Open
Silk fibroin nanoparticles (SFNs) have been widely investigated for drug delivery, but their clinical application still faces technical (large-scale and GMP-compliant manufacturing), economic (cost-effectiveness in comparison to other poly…
View article: Molecular mechanism underlying impaired hepatic autophagy in glycogen storage disease type Ib
Molecular mechanism underlying impaired hepatic autophagy in glycogen storage disease type Ib Open
Type Ib glycogen storage disease (GSD-Ib) is caused by a deficiency in the glucose-6-phosphate (G6P) transporter (G6PT) that translocates G6P from the cytoplasm into the endoplasmic reticulum lumen, where the intraluminal G6P is hydrolyzed…
View article: Dapagliflozin Prevents Kidney Glycogen Accumulation and Improves Renal Proximal Tubule Cell Functions in a Mouse Model of Glycogen Storage Disease Type 1b
Dapagliflozin Prevents Kidney Glycogen Accumulation and Improves Renal Proximal Tubule Cell Functions in a Mouse Model of Glycogen Storage Disease Type 1b Open
Background Mutations in SLC37A4 , which encodes the intracellular glucose transporter G6PT, cause the rare glycogen storage disease type 1b (GSD1b). A long-term consequence of GSD1b is kidney failure, which requires KRT. The main protein m…
View article: Exosomal MicroRNAs as Potential Biomarkers of Hepatic Injury and Kidney Disease in Glycogen Storage Disease Type Ia Patients
Exosomal MicroRNAs as Potential Biomarkers of Hepatic Injury and Kidney Disease in Glycogen Storage Disease Type Ia Patients Open
Glycogen storage disease type Ia (GSDIa) is an inherited metabolic disorder caused by mutations in the enzyme glucose-6-phosphatase-α (G6Pase-α). Affected individuals develop renal and liver complications, including the development of hepa…
View article: The SGLT2-inhibitor dapagliflozin improves neutropenia and neutrophil dysfunction in a mouse model of the inherited metabolic disorder GSDIb
The SGLT2-inhibitor dapagliflozin improves neutropenia and neutrophil dysfunction in a mouse model of the inherited metabolic disorder GSDIb Open
View article: Circulating exosomal microRNAs as potential biomarkers of hepatic injury and inflammation in a murine model of glycogen storage disease type 1a
Circulating exosomal microRNAs as potential biomarkers of hepatic injury and inflammation in a murine model of glycogen storage disease type 1a Open
Most patients affected by glycogen storage disease type 1a (GSD1a), an inherited metabolic disorder caused by mutations in the enzyme glucose-6-phosphatase-α (G6Pase-α), develop renal and liver complications, including the development of h…
View article: SP014RENAL PHENOTYPE OF A MOUSE MODEL OF GLYCOGENOSIS I TYPE B
SP014RENAL PHENOTYPE OF A MOUSE MODEL OF GLYCOGENOSIS I TYPE B Open
INTRODUCTION: Glycogenosis I type b (Gsd1b) is a rare metabolic disease characterized by hepato-renal glycogen accumulation caused by a deficiency in the Glucose-6-phosphate transporter and characterized by impaired glucose homeostasis, my…
View article: Hepatocellular adenoma classification using MRI and identification of biomarkers for prediction of liver tumor onset in a mouse model of glycogen storage disease type1a.
Hepatocellular adenoma classification using MRI and identification of biomarkers for prediction of liver tumor onset in a mouse model of glycogen storage disease type1a. Open
The purpose of my thesis is to specify the feminine world (compared to the masculine one), from the viewpoint of onomastics, in the reality of Chieri -Turin-), a settlement with a thousand-year history, in the transition from the end of th…
View article: Characterization of high- and low-risk hepatocellular adenomas by magnetic resonance imaging in an animal model of glycogen storage disease type 1A
Characterization of high- and low-risk hepatocellular adenomas by magnetic resonance imaging in an animal model of glycogen storage disease type 1A Open
Hepatocellular adenomas (HCAs) are benign tumors, of which the most serious complications are hemorrhage and malignant transformation to hepatocellular carcinoma (HCC). Among the various subtypes of HCA, the β-catenin-activated subtype (bH…